Update shared on 04 Nov 2025
Fair value Increased 4.18%Analysts have raised their price target for CRA International from $239.50 to $249.50, citing a slightly reduced discount rate and improved profit margin expectations as key factors behind the revision.
What's in the News
- CRA International updated its share buyback program, repurchasing 21,532 shares between June 29 and September 27, 2025. This completes 74.69% of the repurchase program announced in 2010 (Key Developments).
- The company increased its quarterly cash dividend by 16%, raising it from $0.49 to $0.57 per common share. The dividend is payable December 12, 2025 to shareholders of record as of November 25, 2025 (Key Developments).
- CRA International raised its full-year fiscal 2025 guidance and now expects revenue in the range of $740.0 million to $748.0 million, compared to prior expectations of $730.0 million to $745.0 million (Key Developments).
Valuation Changes
- Fair Value Estimate has risen from $239.50 to $249.50, reflecting an increase of about 4%.
- Discount Rate has fallen slightly from 7.30% to 7.25%.
- Revenue Growth Expectation has decreased from 4.86% to 3.82%.
- Net Profit Margin Projected has improved from 7.30% to 7.98%.
- Future P/E Ratio Estimate has declined significantly from 29.61x to 23.56x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.